biotech / news / / NDTV.com
Danish pharmaceutical major Novo Nordisk announced a strategic partnership with OpenAI to deploy advanced artificial intelligence across its operations.
Novo Nordisk will fully integrate OpenAI's AI across its value chain by end of 2026.
KEY POINTS
- AI will be used to analyse complex datasets and identify potential drug candidates faster.
- Pilot AI programmes will launch in research, manufacturing, and commercial functions before full rollout.
- OpenAI will help upskill Novo Nordisk's workforce to enhance AI literacy globally.
- The partnership includes strict data protection, governance, and human oversight for ethical AI use.
COMPANIES
Summarized by Newsio from NDTV.com. How we summarize →